Insider Transactions in Q3 2024 at Intuitive Surgical Inc (ISRG)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 13
2024
|
Amy L Ladd Director |
SELL
Open market or private sale
|
Direct |
450
-35.41%
|
$220,500
$490.28 P/Share
|
Sep 12
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
2,115
-87.76%
|
$1,038,465
$491.91 P/Share
|
Sep 12
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
BUY
Exercise of conversion of derivative security
|
Direct |
2,115
+46.74%
|
$124,785
$59.46 P/Share
|
Sep 10
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
238
-2.12%
|
$113,526
$477.5 P/Share
|
Sep 10
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
238
+2.07%
|
$63,546
$267.03 P/Share
|
Sep 09
2024
|
Gary Loeb General Counsel |
SELL
Open market or private sale
|
Direct |
300
-15.83%
|
$142,500
$475.0 P/Share
|
Aug 31
2024
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
1,698
-50.72%
|
$835,416
$492.63 P/Share
|
Aug 31
2024
|
Marshall Mohr Executive VP Global Business S |
BUY
Grant, award, or other acquisition
|
Direct |
3,348
+50.0%
|
-
|
Aug 29
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
188
-3.3%
|
$90,616
$482.21 P/Share
|
Aug 29
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
188
+3.2%
|
$39,104
$208.9 P/Share
|
Aug 28
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
188
-3.3%
|
$90,616
$482.93 P/Share
|
Aug 28
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
188
+3.2%
|
$54,520
$290.33 P/Share
|
Aug 26
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
396
-3.47%
|
$192,456
$486.88 P/Share
|
Aug 26
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
396
+3.35%
|
$117,216
$296.51 P/Share
|
Aug 23
2024
|
Henry L Charlton SVP & Chief Commercial and Mkt |
SELL
Open market or private sale
|
Direct |
40,243
-16.45%
|
$19,558,098
$486.84 P/Share
|
Aug 23
2024
|
Henry L Charlton SVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
19,758
+6.68%
|
$2,509,266
$127.26 P/Share
|
Aug 12
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
240
-2.13%
|
$111,360
$464.76 P/Share
|
Aug 12
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
240
+2.09%
|
$64,080
$267.03 P/Share
|
Aug 01
2024
|
Amal M Johnson |
SELL
Open market or private sale
|
Direct |
2,943
-19.34%
|
$1,303,749
$443.3 P/Share
|
Aug 01
2024
|
Amal M Johnson |
BUY
Exercise of conversion of derivative security
|
Direct |
2,943
+16.21%
|
$208,953
$71.32 P/Share
|
Jul 30
2024
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Indirect |
7,440
-13.6%
|
$3,310,800
$445.1 P/Share
|
Jul 30
2024
|
Gary S Guthart CEO |
SELL
Bona fide gift
|
Indirect |
12,500
-1.04%
|
-
|
Jul 30
2024
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Direct |
23,388
-57.67%
|
$10,360,884
$443.07 P/Share
|
Jul 30
2024
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,200
+38.32%
|
$1,436,400
$57.11 P/Share
|
Jul 29
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
376
-3.3%
|
$167,696
$446.6 P/Share
|
Jul 29
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
376
+3.2%
|
$93,624
$249.61 P/Share
|
Jul 26
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Open market or private sale
|
Direct |
1,413
-4.06%
|
$618,894
$438.6 P/Share
|
Jul 26
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
1,413
+3.87%
|
$382,923
$271.05 P/Share
|
Jul 23
2024
|
Craig H Barratt Director |
SELL
Open market or private sale
|
Direct |
1,400
-100.0%
|
$641,200
$458.13 P/Share
|
Jul 23
2024
|
Craig H Barratt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,400
+50.0%
|
$78,400
$56.97 P/Share
|
Jul 23
2024
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,818
-90.44%
|
$1,290,644
$458.13 P/Share
|
Jul 23
2024
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,818
+47.49%
|
$498,786
$177.99 P/Share
|